Abstract
Synchronous squamous cell carcinoma of the lung and type AB thymoma - is effective radical treatment possible?
Highlights
Secondary neoplasms occur in 8-31% of patients with primary thymic tumors and are mostly diagnosed after thymic cancer treatment
Thymectomy was selected before the thymic tumor histology had been established
The clinical stages of squamous cell carcinoma and thymoma were post-operatively determined as IIB and Masaoka-Koga III, respectively
Summary
Secondary neoplasms occur in 8-31% of patients with primary thymic tumors and are mostly diagnosed after thymic cancer treatment. A 71-year-old man with hypertension, type 2 diabetes, chronic obstructive pulmonary disease and long-term nicotinism was referred to us following incidental detection of a left-lung tumor on chest X-ray. Radiology suggested primary thymic and lung cancers and revealed no enlarged mediastinal nodes or other abnormalities. The pathological diagnosis was squamous cell lung carcinoma of pT3N0M0 stage (clinical stage IIB) due to parietal pleura involvement (Figure 2A) and type AB thymoma (Masaoka-Koga stage III due to microscopically confirmed mediastinal pleura infiltration) (Figure 2B). Based on the lung cancer stage, standard adjuvant chemotherapy was administered (cisplatin 80mg/m2 day 1, vinorelbine 30mg/m2 days 1, 8; every 21 days). Knetki-Wróblewska M (2019) Synchronous squamous cell carcinoma of the lung and type AB thymoma - is effective radical treatment possible?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.